Table 3.
Between-country comparison of COVID-19 disease burden
| Country and analysis period | Estimation of total symptomatic infected | Life expectancy table | Mortality due to COVID | Include post-acute | DALY/100,000 | % YLD |
|---|---|---|---|---|---|---|
|
Netherlands [2020] |
Yesa (evidence synthesis) | GBD-2019 | Statistics Netherlands registered (confirmed + suspected) | No | 1640 (1620–1670) | 1% |
|
Scotland [2020] |
Yes (SEIR modelling) | GBD-2019 | Death registry (confirmed only or confirmed + suspected) | Yes, limited | 1770–1980 | 2% |
|
Germany [2020] |
No (notified positives only) | Germany 2016/2018 | Deaths among notified cases | No | 368 | 0.7% |
|
Malta [7 Mar 2020—31 Mar 2021] |
Yes (notified positives adjusted for underascert.) | GBD-2019 | Daily COVID-19 bulletins issued by Malta Ministry of Health | Yes, limited | 1086b | 5% |
aFor the Netherlands, 'total symptomatic infected' is derived using the ECDC case definition (see "Methods")
bCalculated based on the reported estimate of 5478 DALY, in population size of 505,200 (estimate for 2019; World Bank)